{"id":46309,"date":"2016-06-27T09:00:00","date_gmt":"2016-06-27T13:00:00","guid":{"rendered":"http:\/\/hispanicprwire.com\/if-you-purchased-prograf-not-for-resale-you-may-be-entitled-to-money-from-a-class-action-settlement\/"},"modified":"2016-06-27T09:02:10","modified_gmt":"2016-06-27T13:02:10","slug":"si-usted-compro-prograf-no-para-reventa-podria-tener-derecho-a-recibir-una-indemnizacion-derivada-de-un-acuerdo-de-conciliacion-por-demanda-colectiva","status":"publish","type":"post","link":"https:\/\/hispanicprwire.com\/en\/si-usted-compro-prograf-no-para-reventa-podria-tener-derecho-a-recibir-una-indemnizacion-derivada-de-un-acuerdo-de-conciliacion-por-demanda-colectiva\/","title":{"rendered":"If You Purchased Prograf (Not for Resale), You May Be Entitled to Money from a Class Action Settlement"},"content":{"rendered":"<p><\/p>\n<style type=\"text\/css\"><![CDATA[\n\/* Style Definitions *\/\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n.prngen2{\nBORDER-TOP:1pt; BORDER-RIGHT:1pt; VERTICAL-ALIGN: BOTTOM; BORDER-BOTTOM:1pt; TEXT-ALIGN: CENTER; PADDING-LEFT:0.50em; BORDER-LEFT:1pt; PADDING-RIGHT:0.50em\n}\n.prntblns{\nBORDER-TOP: 1pt; BORDER-RIGHT: 1pt; BORDER-COLLAPSE: collapse; BORDER-BOTTOM: 1pt; BORDER-LEFT: 1pt\n}\n]]><\/style>\n<div class=\"xn-content\">\n<p><span class=\"xn-location\">NASHVILLE, Tennessee<\/span>, <span class=\"xn-chron\">June 27, 2016<\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212;<b>\u00a0<\/b>The following statement is being issued by Branstetter, Stranch &amp; Jennings, PLLC regarding <i>In<\/i> <i>re Prograf Antitrust Litigation<\/i>.<\/p>\n<p>A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (&#8220;Astellas&#8221; or &#8220;Defendant&#8221;) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf\u00ae (known as tacrolimus).\u00a0 Plaintiffs allege that Defendant&#8217;s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from <span class=\"xn-chron\">September 3, 2008<\/span> to <span class=\"xn-chron\">December 31, 2010<\/span> (also referred to as the &#8220;Class Damage Period&#8221;).\u00a0This lawsuit does <b><u>not<\/u> <\/b>claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.<\/p>\n<p><b><u>Are You Affected?<\/u><\/b> As a <b><i>Consumer<\/i><\/b>, you may be a member of the Settlement Class if you paid for some or all of the purchase price for Prograf and\/or its generic equivalent, in capsule form, for consumption by yourself or a member of your family any time between <span class=\"xn-chron\">April 15, 2008<\/span> and <span class=\"xn-chron\">December 31, 2010<\/span> (the &#8220;Class Period&#8221;) in <span class=\"xn-location\">Arizona<\/span>, <span class=\"xn-location\">California<\/span>, <span class=\"xn-location\">Delaware<\/span>, <span class=\"xn-location\">District of Columbia<\/span>, Florida, <span class=\"xn-location\">Georgia<\/span>, <span class=\"xn-location\">Idaho<\/span>, <span class=\"xn-location\">Illinois<\/span>, <span class=\"xn-location\">Iowa<\/span>, <span class=\"xn-location\">Kansas<\/span>, <span class=\"xn-location\">Maine<\/span>, <span class=\"xn-location\">Massachusetts<\/span>, <span class=\"xn-location\">Michigan<\/span>, <span class=\"xn-location\">Minnesota<\/span>, <span class=\"xn-location\">Mississippi<\/span>, <span class=\"xn-location\">Missouri<\/span>, <span class=\"xn-location\">Nebraska<\/span>, <span class=\"xn-location\">Nevada<\/span>, <span class=\"xn-location\">New Hampshire<\/span>, <span class=\"xn-location\">New Mexico<\/span>, <span class=\"xn-location\">New York<\/span>, <span class=\"xn-location\">North Carolina<\/span>, <span class=\"xn-location\">North Dakota<\/span>, <span class=\"xn-location\">Oregon<\/span>, <span class=\"xn-location\">Pennsylvania<\/span>, <span class=\"xn-location\">Puerto Rico<\/span>, <span class=\"xn-location\">Rhode Island<\/span>, <span class=\"xn-location\">South Dakota<\/span>, <span class=\"xn-location\">Tennessee<\/span>, <span class=\"xn-location\">Vermont<\/span>, <span class=\"xn-location\">West Virginia<\/span>, or Wisconsin.\u00a0 As a <b><i>Third-Party Payor<\/i><\/b>, you may be a member of the Settlement Class if you paid for some or all of the purchase price for Prograf and\/or its generic equivalent, in capsule form, for consumption by your members, employees, insureds, participants, or beneficiaries (including government-funded employee benefit plans) and not for resale in at least one of the above-listed states during the Class Period. <\/p>\n<p><b><u>What Are Your Rights And Options?<\/u><\/b> Stay in the class and file and claim: To share in the distribution of the Net Settlement Fund, you must file a claim form on or before <b><span class=\"xn-chron\">December 6, 2016<\/span><\/b>.\u00a0 Claim forms may be requested online at <a href=\"http:\/\/www.prografindirectpurchasersettlement.com\/\" target=\"_blank\" rel=\"nofollow\">www.PrografIndirectPurchaserSettlement.com<\/a> or by writing to Prograf Indirect Purchaser Settlement, c\/o GCG, P.O. Box 10112, <span class=\"xn-location\">Dublin, OH<\/span> 43017-3112. <\/p>\n<p><b><u>Exclude Yourself<\/u><\/b>: If you do not want to be included as a Class Member, you must exclude yourself by submitting a written Request for Exclusion (available at <a href=\"http:\/\/www.prografindirectpurchasersettlement.com\/\" target=\"_blank\" rel=\"nofollow\">www.PrografIndirectPurchaserSettlement.com<\/a>) to the Settlement Administrator at the address above by <b><span class=\"xn-chron\">September 8, 2016<\/span><\/b>. If you exclude yourself, you get no benefits, but keep your right to file your own lawsuit. Third Party Payors should visit the website for a complete list of items required in your exclusion request. <b>Any Third Party Payor included in the Settlement Class that does not submit a valid request for exclusion providing all necessary information and documentation will be bound by the terms of the Settlement.\u00a0<\/b>Further, all members of the Settlement Class who have not requested exclusion from the Class will be bound by the Settlement entered in the Action even if they do not file a timely Proof of Claim.<\/p>\n<p><b><u>Do Nothing<\/u><\/b>: If you do nothing, you are choosing to stay in the Settlement Class and will be bound by the Settlement Agreement and future Court rulings. <\/p>\n<p>Inquiries should NOT be directed to Defendants, the Court, or the Clerk of the Court. Inquiries, other than requests for the Notice or for a claim form, may be made to Class Counsel at the following addresses:<\/p>\n<div>\n<table cellspacing=\"0\" cellpadding=\"0\" border=\"0\" class=\"prntblns\">\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">J. Gerard Stranch, IV <\/span><\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">James R. Dugan, II<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Joe P. Leniski, Jr.<\/span><\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Douglas Plymale, Ph.D.<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">\u00a0<b>BRANSTETTER, STRANCH &amp;<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">David Franco<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>\u00a0JENNINGS, PLLC<\/b><\/span><\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\"><b>DUGAN LAW FIRM<\/b><\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">The Freedom Center<\/span><\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">One Canal Place<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">223 Rosa L. Parks Avenue, Suite 200<\/span><\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">365 Canal St., Suite 1000<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Nashville, TN\u00a0 37203<\/span><\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">New Orleans, LA 70130<\/span><\/p>\n<\/td>\n<\/tr>\n<tr>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Tel: (615) 254-8801<\/span><\/p>\n<\/td>\n<td class=\"prngen2\">\n<p class=\"prnews_p\"><span class=\"prnews_span\">Tel: (504) 648-0180<\/span><\/p>\n<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<p>\u00a0<\/p>\n<p>A hearing will be held on <span class=\"xn-chron\">November 2, 2016<\/span>, at <span class=\"xn-chron\">2:00 p.m. Eastern Time<\/span>, before the Honorable Rya W. Zobel in Courtroom 12 of the United States District Court for the District of <span class=\"xn-location\">Massachusetts<\/span>, <span class=\"xn-location\">United States<\/span> Courthouse, 1 Courthouse Way, <span class=\"xn-location\">Boston, MA<\/span> 02210 to determine, among other things, whether the proposed settlement should be approved by the Court as fair, reasonable and adequate.<\/p>\n<p><b><u>Want More Information?<\/u><\/b> This notice is only a summary. More information can be found at <a href=\"http:\/\/www.prografindirectpurchasersettlement.com\/\" target=\"_blank\" rel=\"nofollow\">www.PrografIndirectPurchaserSettlement.com<\/a>, by calling 1-844-322-8238, writing to Prograf Indirect Purchaser Settlement, c\/o GCG, P.O. Box 10112, <span class=\"xn-location\">Dublin, OH<\/span> 43017-3112 or by email at <a href=\"mailto:Questions@PrografIndirectPurchaserSettlement.com\" target=\"_blank\" rel=\"nofollow\">Questions@PrografIndirectPurchaserSettlement.com<\/a>.<\/p>\n<\/div>\n<p> <\/p>","protected":false},"excerpt":{"rendered":"<div class=\"xn-content\">\n<p><span class=\"xn-location\">NASHVILLE, Tennessee<\/span>, <span class=\"xn-chron\">June 27, 2016<\/span> \/PRNewswire-HISPANIC PR WIRE\/ &#8212;<b>\u00a0<\/b>The following statement is being issued by Branstetter, Stranch &amp; Jennings, PLLC regarding <i>In<\/i> <i>re Prograf Antitrust Litigation<\/i>.<\/p>\n<p>A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (&#8220;Astellas&#8221; or &#8220;Defendant&#8221;) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-46309","post","type-post","status-publish","format-standard","hentry","category-negocios-y-finanzas"],"acf":[],"_links":{"self":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/46309","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/comments?post=46309"}],"version-history":[{"count":0,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/posts\/46309\/revisions"}],"wp:attachment":[{"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/media?parent=46309"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/categories?post=46309"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hispanicprwire.com\/en\/wp-json\/wp\/v2\/tags?post=46309"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}